Michael Stocum
Impact in
- Pharmacology top 5%
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- ATP Synthase and ATPases Research 1
- Oncology 2
- Co-authors
- Katherine L. Baker-Neblett (1 shared paper)William Spreen (1 shared paper)Eric Lai (1 shared paper)Mary E. Fling (1 shared paper)Linda M. Thurmond (1 shared paper)Denise Shortino (1 shared paper)Seth Hetherington (1 shared paper)Allen D. Roses (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)Journal of Molecular Diagnostics (1 paper)Drug Information Journal (1 paper)New Biotechnology (1 paper)The Lancet (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Michael Stocum
6 papers receiving 740 citations
Michael Stocum's Hit Papers
Peers
Comparison fields: 5 of 79
- Pharmacology 324
- Virology 80
- Pharmacology 107
- Toxicology 29
- Rheumatology 116
Countries citing papers authored by Michael Stocum
This map shows the geographic impact of Michael Stocum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Stocum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Stocum more than expected).
Fields of papers citing papers by Michael Stocum
This network shows the impact of papers produced by Michael Stocum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Stocum. The network helps show where Michael Stocum may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Stocum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Genetic variations in HLA-B region and hypersensitivity reactions to abacavir Hit paper breakdown → | 2002 | 583 |
| 2 | 2012 | 162 | |
| 3 | 2012 | 12 | |
| 4 | 2023 | 6 | |
| 5 | 2013 | 4 | |
| 6 | 2012 | 1 | |
| 7 | Use of flow-through peptide-microarrays for cell-lysate profiling | 2006 | 1 |
About Michael Stocum
Michael Stocum is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Pharmacology, having authored 7 papers that have together received 769 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Urticaria and Related Conditions (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), ATP Synthase and ATPases Research (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Biotechnology and Related Fields (1 paper). The work is most often cited by research in Pharmacology (324 citations), Virology (80 citations), Pharmacology (107 citations), Toxicology (29 citations) and Rheumatology (116 citations). Michael Stocum has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Katherine L. Baker-Neblett, William Spreen, Eric Lai, Mary E. Fling, Linda M. Thurmond, Denise Shortino, Seth Hetherington, Allen D. Roses, Michael Mosteller and Arlene R. Hughes. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Molecular Diagnostics, Drug Information Journal, New Biotechnology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.